Hearing loss is a significant preexisting condition among patients infected with human immunodeficiency virus (HIV). Difficulty hearing can interfere with the communication of important health care information from provider to patient, including information on preventing HIV transmission and opportunistic illnesses associated with HIV. In addition, infectious disease treatments such as aminoglycoside antibiotics, which are ototoxic, may contribute to hearing impairments. To determine the prevalence of hearing loss among HIV-infected patients, we examined data in the Adult Spectrum of HIV Disease (ASD) project, a multicenter medical record review surveillance initiative conducted in 11 US cities. The methods used in ASD have been previously described.1,2 Medical records of ASD enrollees are retrospectively reviewed for the 12-month period prior to their enrollment date, and at subsequent 6-month intervals until patient death or loss to follow-up.
McNaghten AD, Wan PT, Dworkin MS. Prevalence of Hearing Loss in a Cohort of HIV-Infected Patients. Arch Otolaryngol Head Neck Surg. 2001;127(12):1516–1518. doi:
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.